Identification of the Potential of Plant-Derived Agents to Act as KRAS G12D Inhibitors Through Molecular Docking, Molecular Dynamics Simulations, and MMGBSA.

Okutan E, Özışık S, Atalay VE

Open source

DOI
10.2174/0113816128502014260805105813
Published
2026 Aug 21
Container
Current pharmaceutical design
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113816128502014260805105813,
  title = {Identification of the Potential of Plant-Derived Agents to Act as KRAS G12D Inhibitors Through Molecular Docking, Molecular Dynamics Simulations, and MMGBSA.},
  author = {Okutan E and Özışık S and Atalay VE},
  year = {2026},
  journal = {Current pharmaceutical design},
  doi = {10.2174/0113816128502014260805105813},
  url = {https://doi.org/10.2174/0113816128502014260805105813}
}

RIS

TY  - JOUR
TI  - Identification of the Potential of Plant-Derived Agents to Act as KRAS G12D Inhibitors Through Molecular Docking, Molecular Dynamics Simulations, and MMGBSA.
AU  - Okutan E
AU  - Özışık S
AU  - Atalay VE
PY  - 2026
JO  - Current pharmaceutical design
DO  - 10.2174/0113816128502014260805105813
UR  - https://doi.org/10.2174/0113816128502014260805105813
ER  - 

APA

E, O., S, Ö., & VE, A. (2026). Identification of the Potential of Plant-Derived Agents to Act as KRAS G12D Inhibitors Through Molecular Docking, Molecular Dynamics Simulations, and MMGBSA.. Current pharmaceutical design. https://doi.org/10.2174/0113816128502014260805105813

Source records